Scientific News The Latest Analyst Ratings For Boston Scientific
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News The Latest Analyst Ratings For Boston Scientific is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific Delivers Robust Q3 Despite Tariff Headwinds: Analyst
Boston Scientific posts $5.07 billion in Q3 revenue, beats earnings estimates, sees WATCHMAN growth at 35%, and raises 2025 sales forecast. Read More
Boston Scientific’s Financial Outlook: Key Risks and Challenges Highlighted in Latest Annual Report
Boston Scientific (BSX) has disclosed a new risk, in the Regulation category. Boston Scientific faces significant business risks that could impact ... Read More
Do Wall Street Analysts Like Boston Scientific Stock?
With a market cap of $149 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets innovative medical devices used in various interventional medical specialties worldwide. It ... Read More
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?
Boston Scientific Corp. (NYSE: BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More
Is It Worth Investing in Boston Scientific (BSX) Based on Wall Street's Bullish Views?
Boston Scientific (BSX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock ... Read More
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) ... Read More
What the Options Market Tells Us About Boston Scientific
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 40% bearish. Among these notable options, 2 are puts, totaling $105,000, and 13 are calls, amounting to $731 ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus